Chemical Name:11,12,13,13a-Tetrahydro-7-methoxy-9-oxo-9H-imidazo[1,5-
a]pyrrolo[2,1-c][1,4]benzodiazepine-1-carboxylic acid,
ethyl ester
Biological Activity:
Potent, selective inverse agonist
for the benzodiazepine site of GABAA receptors containing the α5
subunit (Ki = 0.45 nM). Displays 50-100-fold selectivity over GABAA
receptors containing α1, α2,
α3 or α6 subunits in
combination with β3 and γ2.
Enhances LTP ina mouse hippocampal
slice model and increases spatial learning, without displaying proconvulsant
activity.
Quirket
al (1996) [3H]L-655,708, a novel ligand selective for the
benzodiazepine site of GABAA receptors which contain the α5 subunit.
Neuropharmacology 35 1331. Suret al (1998) Rat and
human hippocampal α5 subunit-containing γ-aminobutyric acidA receptors
have α5β3γ2 pharmacological characteristics. Mol.Pharmacol. 54 928. Atacket al (2006) L-655,708 enhances cognition in rats but is not
proconvulsant at a dose selective for α5-containing GABAA receptors.
Neuropharmacology 51 1023.
Selective antagonist of neuro-steroid potentiation and direct gating of GABAA receptors. Selectively reduces the effects of 5α-reduced steroids compared to 5β-reduced steroids & displays no effect on potentiation evoked by barbiturates & benzodiazepines. Attenuates 3α,5α-THP-induced loss of righting reflex and total sleep time following i.c.v administration in rats.